Symrise Sells Terpene Ingredients Business
Symrise AG has signed an agreement to sell AmeriTerpenes LLC, its terpene ingredients business, to Mutares SE & Co. KGaA, an international private equity investor. Symrise's ONE Symrise strategy is furthered by this divestment, which sharpens its portfolio and focuses management attention on core growth platforms. AmeriTerpenes is positioned to further develop its renewable terpene ingredient portfolio for fragrance, flavour, and industrial applications under focused ownership, and customer continuity is supported by the agreement.
AmeriTerpenes, a prominent manufacturer of renewable terpene ingredients, is serving customers in the fragrance, flavour, and industrial sectors from its manufacturing facilities in Jacksonville, Florida and Colonels Island, Georgia. In fragrance, flavour, and industrial formulations, customers seek renewable, consistent, and high-performing ingredient solutions. Terpene ingredients are an essential component of these formulations. Having completed the operational carve-out over the past few months, the business is well-positioned to continue its growth under the new ownership entity.
Symrise's long-term objective of achieving sustainable profitable growth, operational excellence, and disciplined capital allocation under the ONE Symrise strategy is further supported by the divestiture, which further refines its portfolio and increases management focus on its core growth platforms.
Dr Jean-Yves Parisot, CEO of Symrise AG, commented: "This transaction gives a good example of how we are actively shaping Symrise for the future with continued portfolio management: AmeriTerpenes is a strong business with excellent people, longstanding customer relationships and differentiated manufacturing capabilities. We are pleased that, with Mutares, we have found an experienced owner that brings a strong operational track record in corporate carve-outs and is well-suited to support AmeriTerpenes into its future. We also look forward to continuing our partnership with AmeriTerpenes and Mutares as its new owner through strategic agreements entered into as part of the transaction."
The acquisition of AmeriTerpenes represents a new platform investment for Mutares' Chemicals & Materials segment and further strengthens the Group's footprint in the strategically important U.S. market.
Johannes Laumann, CIO of Mutares, commented: "With this transaction, we are adding a strong platform to our Chemicals & Materials segment while further strengthening our presence in the U.S. market. As a corporate carve-out, the company offers exactly the type of special situation, for which we have designed our investment approach. This deal marks the promise to deliver our strategy of strong growth in the segment and the U.S. market."
Symrise and Mutares are committed to ensuring a seamless transition, maintaining business continuity, customer service excellence and strong relationships with customers and suppliers. Following closing, Symrise and AmeriTerpenes will continue their long-standing commercial relationship. The agreed supply arrangements secure long-term access to renewable, terpene-based raw materials and create an enduring industrial partnership that supports both companies’ future growth plans.
The signing and closing of the transaction took place simultaneously. Both parties to the transaction have agreed to keep financial details relating to the transaction confidential.
The transaction is expected to result in a non-cash disposal loss amounting to a mid-double-digit million-euro impact, which will reflect in Symrise's annual financial statements 2026.
Source: Symrise
